Send to

Choose Destination
See comment in PubMed Commons below
Rev Neurol (Paris). 2012 Nov;168(11):802-5. doi: 10.1016/j.neurol.2012.07.002. Epub 2012 Sep 13.

Designing primate models to assess the prodromal phase of Huntington's disease.

Author information

Atomic energy commission (CEA), Institute of biomedical imaging (I2BM), Molecular imaging research center (MIRCen), 18 route du Panorama, 92260 Fontenay-Aux-Roses, France.


Huntington's disease (HD) is an inherited autosomal-dominant neurodegenerative disorder characterized by frontal-type cognitive deficits, involuntary choreiform movements and progressive neuronal degeneration, primarily affecting the caudate-putamen complex. There is currently no effective therapy for this disorder. Numerous efforts are directed towards the search and validation of new therapies to prevent or slow down disease progression. To this end, different animal models, including in nonhuman primates, have been developed to mimic the early phase of neuronal dysfunction that precedes degeneration in this pathology. The present manuscript provides a critical evaluation of existing and currently developed primate models of Huntington's disease. Their pertinence and predictability for the evaluation of innovative therapeutic strategies are also discussed.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Masson (France)
    Loading ...
    Support Center